XNAS · BIVI
+2.75% · +$0.0600 · Vol 112.0K
After hours · updated 16:00:00 ET
BioVie, Inc. Common Stock

BioVie, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$2.24
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is BIVI moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About BioVie, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2014
Employees
13
Country
US

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.17
Day high
$2.30
Day low
$2.10
Previous close
$2.18
52W high
$2.30
-2.61% from high
52W low
$1.63
91% of range
Market cap
$16.4M
EPS
$-2.6000
Shares out
7.5M
Volume
112K
VWAP
$2.22
Price history computed in-house
1W
+14.87%
1M
+37.42%
SMA 50 $1.90 · above
SMA 200 $1.90 · above
52W position 91%
Veridion warehouse edge

Warehouse intelligence for BIVI.

Veridion Score
73
0: 941: 522: 783: 204: 795: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

BIVI insider activity

BioVie, Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for BIVI.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

BIVI contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BIVI in this window.
Lobbying spend

BIVI lobbying filings, year to date.

Registered lobbying filings matched to BioVie, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BIVI in this window.
Latest news · BIVI
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for BIVI.
Options
Sovereign unlock shows live options positioning for BIVI.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.